Apteka Św.Łukaszasp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-08-23
Share capital
50,000.00 PLN
Registered address
Piłsudskiego 15, 05-510 Konstancin-Jeziorna, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 28 days early.

  • 202503/07/2026
  • 202430/06/2025
  • 202326/06/2024
  • 202228/06/2023
  • 202129/04/2022
  • 202020/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.25mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -40.85kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 3.25mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 564.03kMedianUSD 544.32kAverageUSD 1.76m

Authorized Representatives

Małgorzata Teresa Magiera – Vice President of the Management Board
Tomasz Magiera – President of the Management Board

Manner of representation

In the case of a multi-member management board, the following are authorized to make declarations of will on behalf of the company: - the President of the Management Board and the Vice-President each independently; - a member of the management board only jointly with the President or the Vice-President of the Management Board.

Ownership

OwnerSharesShare valueStake
Małgorzata Teresa Magieraage 71
67$9,049.1667%
Tomasz Magieraage 41
33$4,457.0533%

Małgorzata Teresa Magiera and Tomasz Magiera hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2002-08-30.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 17,773

Public aid

4 public aid cases recorded, with a total value of $103,047.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,209
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$5,025
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$87,285

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
DR ZdrowieS.A.
MagmaxS.A.
Adpharmasp. z o.o.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2017-03-13Switch to PKD 2007
2002-08-23Entered in the register

FAQ

Last updated: 2026-07-06